New Treatment Paradigms in CAD/PAD: When and How to Switch Therapy
Target Audience
Learning Objectives
- Have greater competence related to
- Tailoring antithrombotic strategy in patients with stable CAD and polyvascular disease
- Use of antithrombotic therapy in patients with stable PAD
- 0.25 AMA PRA Category 1 Credit™
- 0.25 Nursing Contact Hours
- 0.25 Participation
FACULTY
Professor of Medicine
Duke University Medical Center
Durham, North Carolina, United States
CONTENT REVIEWER
Department of Medicine
Section of Cardiology
University of Chicago Medicine
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit
Click here to view the activity or if you are logged in click on the "Complete Activity" button!